G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
- PMID: 17210620
- PMCID: PMC2077973
- DOI: 10.1136/jnnp.2006.107904
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Abstract
The G2019S leucine-rich repeat kinase 2 gene (LRRK2) mutation has been identified in a significant proportion of familial and sporadic cases of Parkinson's disease (PD). Until now, information on the neuropathological changes associated with the G2019S LRRK2 mutation has been sparse. We report a 77-year-old patient who presented with a 14 year history of PD but, unexpectedly, histopathological examination disclosed mild neuronal loss in the substantia nigra without alpha-synuclein, tau or ubiquitin cytoplasmic inclusions. A G2019S LRRK2 mutation was eventually detected. The present case confirms that clinical PD caused by G2019S mutations can be associated with non-specific nigral degeneration without Lewy bodies.
Conflict of interest statement
Competing interests: None.
References
-
- Paisán‐Ruiz C, Jain S, Evans E W.et al Cloning of the gene containing mutations that cause PARK8‐linked Parkinson's disease. Neuron 200444595–600. - PubMed
-
- Zimprich A, Biskup S, Leitner P.et al Mutations in LRRK2 cause autosomal‐dominant parkinsonism with pleomorphic pathology. Neuron 200444601–607. - PubMed
-
- Di Fonzo A, Tassorelli C, De Mari M.et al Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 200614322–331. - PubMed
-
- Nichols W C, Pankratz N, Hernandez D.et al Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005365410–412. - PubMed
-
- Gilks W P, Abou‐Sleiman P M, Gandhi S.et al A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005365415–416. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical